Total cucurbitacins from Herpetospermum pedunculosum pericarp do better than Hu-lu-su-pian (HLSP) in its safety and hepatoprotective efficacy
Authors
Wen-Ya Liu
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Di Xu
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Zi-Yun Hu
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Hui-Hui Meng
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Qi Zheng
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Feng-Ye Wu
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Xin Feng
Beijing Hospital of Tibetan Medicine, China Tibetology Research Center, Beijing, China
Jun-Song Wang
Center of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing, China
Keywords:
Herpetospermum pedunculosum pericarp, total cucurbitacins, hepatoprotective activity, NMR, median lethal dosage, no observed adverse effect level
Abstract
The pericarp of Herpetospermum pedunculosum (HPP) has traditionally been used for treating jaundice and hepatitis. However, the specific hepatoprotective components and their safety/efficacy profiles remain unclear. This study aimed to characterize the total cucurbitacins (TCs) extracted from HPP and evaluate their hepatoprotective potential. As a reference, Hu-lu-su-pian (HLSP), a known hepatoprotective drug containing cucurbitacins, was used for comparison of chemical composition, effects, and safety. Molecular networking based on UHPLC-MS/MS identified cucurbitacin B, isocucurbitacin B, and cucurbitacin E as the major components in TCs, comprising 70.3%, 26.1%, and 3.6% as determined by RP-HPLC, respectively. TCs treatment significantly reversed CCl4-induced metabolic changes associated with liver damage in a dose-dependent manner, impacting pathways including energy metabolism, oxidative stress and phenylalanine metabolism, and showed superior efficacy to HLSP. Safety evaluation also showed that TCs were safe, with higher LD50 and no observable adverse effect level (NOAEL) values than HLSP. The median lethal dose (LD50) and NOAEL values of TCs were 36.21 and 15 mg/kg body weight (BW), respectively, while the LD50 of HLSP was 14 mg/kg BW. In summary, TCs extracted from HPP demonstrated promising potential as a natural hepatoprotective agent, warranting further investigation into synergistic effects of individual cucurbitacin components.
Keywords: Herpetospermum pedunculosum pericarp, total cucurbitacins, hepatoprotective activity, NMR, median lethal dosage, no observed adverse effect level
Click on "Archives" to access the full archive of scientific preprints. You may use the categories and the search functionality to find select preprints you're interested in.